- Report
- February 2022
- 39 Pages
Global
From €1776EUR$2,000USD£1,552GBP
- Report
- August 2024
- 178 Pages
Global
From €2220EUR$2,500USD£1,940GBP
- Report
- December 2023
- 162 Pages
Global
From €2220EUR$2,500USD£1,940GBP
- Report
- September 2023
- 159 Pages
Global
From €2220EUR$2,500USD£1,940GBP
- Report
- March 2022
- 120 Pages
Global
From €2220EUR$2,500USD£1,940GBP
- Report
- March 2024
- 113 Pages
North America
From €1332EUR$1,500USD£1,164GBP
- Report
- March 2024
- 124 Pages
Middle East, Africa
From €1332EUR$1,500USD£1,164GBP
- Report
- March 2024
- 124 Pages
Europe
From €1332EUR$1,500USD£1,164GBP
- Report
- March 2024
- 125 Pages
Asia Pacific
From €1332EUR$1,500USD£1,164GBP
- Report
- March 2024
- 266 Pages
Global
From €3197EUR$3,600USD£2,794GBP
- Report
- August 2025
- 122 Pages
From €3064EUR$3,450USD£2,677GBP
- Report
- August 2024
- 150 Pages
Global
From €3419EUR$3,850USD£2,988GBP
€4307EUR$4,850USD£3,764GBP
- Report
- August 2024
- 150 Pages
Global
From €3419EUR$3,850USD£2,988GBP
€4307EUR$4,850USD£3,764GBP
- Report
- January 2024
- 150 Pages
Global
From €3419EUR$3,850USD£2,988GBP
€4307EUR$4,850USD£3,764GBP
- Drug Pipelines
- August 2024
- 150 Pages
Global
From €2477EUR$2,789USD£2,164GBP
- Report
- June 2024
- 140 Pages
Europe
From €3436EUR$3,869USD£3,003GBP
- Report
- June 2024
- 140 Pages
Latin America
From €3436EUR$3,869USD£3,003GBP
- Report
- April 2024
- 140 Pages
Global
From €4395EUR$4,949USD£3,841GBP
- Report
- May 2023
- 160 Pages
Global
From €4395EUR$4,949USD£3,841GBP
- Report
- April 2023
- 147 Pages
Global
From €4395EUR$4,949USD£3,841GBP

The Cough and Cold Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of medications used to treat symptoms of the common cold and other respiratory illnesses. These drugs are typically available over-the-counter and are used to reduce the severity of symptoms such as coughing, sneezing, sore throat, and congestion. Common ingredients in these medications include decongestants, antihistamines, expectorants, and pain relievers.
The Cough and Cold Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in this market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Novartis, and Sanofi. These companies have a wide range of products available, from traditional medications to more innovative treatments. Additionally, many smaller companies are also active in this market, offering more specialized products. Show Less Read more